Omega-3 fatty acid supplementation provides an additional benefit to a low-dust diet in the management of horses with chronic lower airway inflammatory disease

Affiliations expand

Abstract

Background: Omega-3 polyunsaturated fatty acid (PUFA) may benefit humans and animals with chronic inflammatory diseases.

Hypothesis: Omega-3 PUFA supplementation improves clinical signs, lung function, and airway inflammation in horses with recurrent airway obstruction (RAO) and inflammatory airway disease (IAD).

Animals: Eight research horses and 35 client-owned horses.

Methods: A pilot study examined the dose of PUFA that can alter plasma PUFA composition. Then, a randomized, controlled clinical trial was performed in horses with RAO and IAD. Horses were fed a complete pelleted diet with no hay and randomly assigned to 1 of 3 daily treatments for 2 months: 30 or 60 g of the supplement or 30 g of placebo. Clinical signs, lung function, plasma PUFA composition, and bronchoalveolar lavage fluid (BALF) cytology were evaluated. Data were expressed as median (25-75th percentiles). P < .05 was considered significant.

Results: Polyunsaturated fatty acid supplementation resulted in increased plasma docosahexaenoic acid (DHA) that peaked at 4 weeks. Clinical improvement was noted in all horses involved in the clinical trial, but the group that received PUFA had greater improvement in clinical signs (cough score improved 60%), lung function (respiratory effort decreased 48%), and BALF (neutrophils decreased from 23 to 9%) when compared to placebo (cough score improved 33%, respiratory effort decreased 27%, BALF neutrophils increased from 11 to 17%; P < .05).

Conclusions and clinical importance: Feeding horses with RAO and IAD a PUFA supplement containing 1.5-3 g DHA for 2 months provides an additional benefit to low-dust diet.

Keywords: Cough; Inflammatory airway disease; Poor performance; Recurrent airway obstruction.

Copyright © 2014 by the American College of Veterinary Internal Medicine.

PubMed Disclaimer

Figures

Figure 1

Visual analog score ( VAS…

Figure 2

Weekly change in visual analog…

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

  1. Couëtil LL, Hoffman AM, Hodgson J, et al. Inflammatory airway disease of horses. J Vet Intern Med 2007;21:356–361. - PubMed

  2. Hotchkiss JW, Reid SW, Christley RM. A survey of horse owners in Great Britain regarding horses in their care. Part 2: Risk factors for recurrent airway obstruction. Equine Vet J 2007;39:301–308. - PubMed

  3. Robinson NE, Karmaus W, Holcombe SJ, et al. Airway inflammation in Michigan pleasure horses: Prevalence and risk factors. Equine Vet J 2006;38:293–299. - PubMed

  4. Couëtil LL, Chilcoat CD, DeNicola DB, et al. Randomized, controlled study of inhaled fluticasone propionate, oral administration of prednisone, and environmental management of horses with recurrent airway obstruction. Am J Vet Res 2005;66:1665–1674. - PubMed

  5. Bertin FR, Ivester KM, Couëtil LL. Comparative efficacy of inhaled albuterol between two hand‐held delivery devices in horses with recurrent airway obstruction. Equine Vet J 2011;43:393–398. - PubMed

Maria Sempe